Spinogenix
Clinical trials sponsored by Spinogenix, explained in plain language.
-
New ALS drug trial aims to slow disease progression
Disease control Not yet recruitingThis study tests whether the experimental drug tazbentetol can slow the progression of ALS, a disease that weakens muscles and affects movement. About 430 adults with ALS will receive either the drug or a placebo. The main goal is to see if tazbentetol helps maintain daily functi…
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug SPG601 aims to boost brain function in fragile x patients
Symptom relief Not yet recruitingThis study tests a new drug called SPG601 in adult men with Fragile X syndrome. The goal is to see if it can improve thinking and brain function. About 248 participants will receive either the drug or a placebo. The study is not yet recruiting.
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC